Onychomycosis treatment system and method
AssigneeDeviceFarm Inc.
InventorsJeffrey N Roe, Timothy C Grammer, Raul Ignacio Barrera-Barraza
Life of this patent
Estimating the term…
Abstract
A system and method includes a nonthermal plasma sub-system with a permeable UV filter for production and delivery of a redox gas solution to treat onychomycosis, wherein the redox gas solution comprises a reactive species dissolved in a perfluorocarbon liquid, and wherein the perfluorocarbon liquid is dispensed onto a gas-permeable membrane and wherein the reactive species may include, alone or in combination, one or more of reactive oxygen, reactive nitrogen, reactive chlorine, or reactive bromine species, and the perfluorocarbon liquid may include perfluorodecalin.
Claims20
A method of treating an infection on a body part comprising:
- a) applying a perfluorocarbon to a body part with an infection,
- b) positioning said body part in a chamber,
- c) Said chamber having a venting louver,
- d) Said venting louver having holes disposed in said venting louver passing through said venting louver,
- e) Said chamber having a nonthermal plasma subunit
- f) Said nonthermal plasma subunit disposed within said chamber such that said body part is proximal to said venting louver and said venting louver is proximal to said nonthermal plasma subunit,
- g) Said nonthermal plasma subunit assembly comprising an electrical control circuit, a high voltage electrode, a dielectric barrier, and a ground electrode,
- h) Said nonthermal plasma subunit having a plasma gas permeable UV filter disposed proximate to said plasma head assembly,
- i) Said gas permeable UV filter having TiO2 compounds attached to the surface of said gas permeable UV filter,
- j) Said gas permeable UV filter having anti-fungal compounds attached to the surface of said gas permeable UV filter,
- k) Said plasma head assembly capable of forming a plasma reactive species proximate to said ground electrode,
- l) Said plasma head producing a reactive species which is in communication with said perfluorocarbon by passing between said plasma head assembly through the said holes in said venting louver to the focus said reactive species on said infected body part.
A device for treating an infection on a body part comprising:
- a) A chamber,
- b) Said chamber having a venting louver,
- c) Said venting louver having holes disposed in said venting louver passing through said venting louver,
- d) Said venting louver divides said chamber into two chambers a first sub chamber and a second sub chamber
- e) Said first sub chamber having a nonthermal plasma subunit,
- f) Said second sub chamber for positioning said body part with an infection in a chamber,
- g) Applying a perfluorocarbon to a body part with an infection,
- h) Said nonthermal plasma subunit assembly comprising an electrical control circuit, a high voltage electrode, a dielectric barrier and a ground electrode,
- i) Said nonthermal plasma subunit having a plasma gas permeable UV filter disposed proximate to said holes in said venting louver,
- j) Said gas permeable UV filter having TiO2 compounds attached to the surface of said gas permeable UV filter,
- k) Said gas permeable UV filter having anti-fungal compounds attached to the surface of said gas permeable UV filter,
- l) Said plasma head assembly capable of forming a plasma reactive species proximate to said ground electrode,
- m) Said plasma head producing a reactive species which is in communication with said perfluorocarbon by passing between said plasma head assembly through the said holes in said venting louver onto said infected body part.
An onychomycosis treatment system for treating an infected body part comprising:
- a) A Chamber,
- b) Said chamber having a venting louver within said chamber,
- c) Said venting louver having holes disposed in said venting louver passing through said venting louver,
- d) Said venting louver divides said chamber into two chambers, a first sub chamber and a second sub chamber,
- e) Said first sub chamber containing a nonthermal plasma subunit,
- f) Said second sub chamber for positioning said body part with an infection in a chamber,
- g) Applying a perfluorocarbon to a body part with an infection,
- h) Placing said body part in said second sub chamber,
- i) Said nonthermal plasma subunit assembly in said first chamber comprising an electrical control circuit, a high voltage electrode, a dielectric barrier and a ground electrode,
- j) Said gas permeable UV filter having TiO2 compounds attached to the surface of said gas permeable UV filter,
- k) Said gas permeable UV filter having anti-fungal compounds attached to the surface of said gas permeable UV filter,
- l) Said plasma head assembly capable of forming a plasma reactive species proximate to said ground electrode,
- m) Said plasma head producing a reactive species which is in communication with said perfluorocarbon by passing between said plasma head assembly through said holes in said venting louver to the focus said reactive species on said infected body part,
- n) setting a timer for the treatment time
- o) removing said body part after said treatment time has expired on said timer.
Dependencies are inferred from the claim text.